SIB-Norwegian Version, Validation and Reliability Study
The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).
|Study Design:||Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
|Official Title:||Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.|
|Study Start Date:||February 2007|
|Study Completion Date:||May 2007|
The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00449384
|Sykehuset Innlandet HF - Sanderud|
|Ottestad, Oppland, Norway, 2312|
|Study Chair:||Knut Engedal, PhD||The Norwegian Centre for Dementia Research (NCDR), Norway|